Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Study uncovers how cancers resist targeted treatment 10
Jan
2022

Scientists have revealed how cancer can resist PARP inhibitors, a precision medicine used to treat thousands of patients worldwide. Find out more

ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer 05
Jan
2022

The Institute of Cancer Research, London, has expressed disappointment that NICE has decided not to recommend olaparib for previously treated, hormone-relapsed metastatic prostate cancer. Find out more

First clinical trial of innovative drug targeting HSF1 pathway begins 31
Dec
2021

The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial. Find out more

See all news articles

Features

Scientific achievements of 2020/2021 10
Dec
2021

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Celebrating one year at the Centre for Cancer Drug Discovery 19
Nov
2021

One year ago we opened the doors to the Centre for Cancer Drug Discovery. To celebrate, we're looking back on the journey to build it, how it has developed over the last year and its exciting future. Find out more

The future of prostate cancer research: what could the next decade bring? 17
Nov
2021

The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. Diana Cano spoke to our scientists about the most exciting research areas that have the potential to revolutionise prostate cancer treatment in years to come. Find out more

See all feature articles